Noninflammatory disorders of female genital tract. Complication associated with artificial fertilization, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Subcutaneous injection of Triptorelin (0.1 mg) 6 days after ICSI. Intervention 2: Control group: Subcutaneous injection of placebo 6 days after ICSI.
Treatment - Drugs
Placebo
Intervention group: Subcutaneous injection of Triptorelin (0.1 mg) 6 days after ICSI
Control group: Subcutaneous injection of placebo 6 days after ICSI
Sponsors
Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age between 20-38; Body mass index (BMI) between 20-30; fresh embryo transfer cycles; 3rd menstrual day serum FSH below 10; absence of low ovarian response according Bologna Criteria Exclusion criteria: unwillingness to continue; absence of good quality embryo; ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Nazari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed